Navigation Links
Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
Date:1/25/2013

HAYWARD, Calif., Jan. 25, 2013 /PRNewswire/ -- Advanced Cell Diagnostics, Inc., a world leader in the field of in situ nucleic acid detection for life science research and clinical diagnostics, today announced the appointment of Evangeline Gonzalez to its executive leadership team as Chief Commercial Officer. In this role, Mrs. Gonzalez will lead the company's global commercialization efforts.  Mrs. Gonzalez will report directly to Advanced Cell Diagnostics CEO, Yuling Luo , Ph.D.

"It was the breakthrough technology and the multi-talented team that attracted me to Advanced Cell Diagnostics. I'm so excited to join the team to help grow the company to the next level," Mrs. Gonzalez said.

Mrs. Gonzalez has more than 17 years of commercialization experience in the biotechnology industry.  She joins Advanced Cell Diagnostics from Life Technologies (formerly Applied Biosystems and Invitrogen), a 3.7 billion dollar company, where she was most recently Chief Marketing Officer of the Life Sciences Division. In this role, she was responsible for facilitating growth, marketing and global market development strategy.  Previously she was Vice President of Market Development and Product Management for several businesses within Life Technologies including Protein Analysis, Sequencing and Molecular Biology Systems. In these roles, she was responsible for driving revenue growth for both existing products and commercializing new breakthrough technologies globally.

"Advanced Cell Diagnostics has achieved several important milestones over the last 3 months including closing a $12 million financing round, successfully introducing our automated RNAscope solution and expanding our commercial team," said Dr. Luo. "Evangeline's  proven track record of commercializing new technologies and her leadership skills are exactly what we need at this phase of our company's growth," Dr. Luo continued.

About Advanced Cell Diagnostics

Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell and tissue‐based diagnostic tests for personalized medicine. The company's products and services are based on its proprietary RNAscope® technology, the first multiplex chromogenic and fluorescent in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single‐molecule sensitivity. RNAscope assays are currently used by hundreds of customers, including all of the global top 10 pharmaceutical companies, world leading academic institutions and many cutting edge biotechnology companies to validate biomarkers for the management of cancer and other diseases.  ACD's industrial partnerships provide the foundation for ACD to develop companion diagnostic tests in conjunction with partners' targeted therapeutics. ACD also pursues internal programs to develop proprietary diagnostic tests in cancer management. Learn more about ACD and RNAscope technology at www.acdbio.com.

Contact:
Steve Chen , Ph.D.
Chief Operating Officer
(510) 259-9802
schen@acdbio.com


'/>"/>
SOURCE Advanced Cell Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. New Advanced High End Brix Refractometer
2. INRS acquires a groundbreaking advanced imaging infrastructure
3. GIN Introduces Advanced Robotics and Dispensing Technnology at SLAS 2013 in Orlando, FL
4. Nanonex Delivered Advanced Nanoimprint Tool NX-B200 to Swinburne University of Technology, Australia
5. University of Pennsylvania Purchases Nanonex Advanced Nanoimprint Tool NX-2600 BA
6. Advanced Polymer Trading to Exhibit at ArabPlast 2013 in Dubai
7. Dallas-Fort Worth Fertility Associates Celebrates First Birth in North Texas from Advanced Trophectoderm Biopsy Screening Technology
8. Advanced manufacturing venture highlights regions economic prospects
9. Advanced Cell Diagnostics Completes $12 Million Series B Financing
10. Highly efficient production of advanced biofuel by metabolically engineered microorganism
11. Merrimack Pharmaceuticals To Present Preliminary Clinical Data For Novel Therapies Targeting Molecular Pathways In Advanced Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... , ... Personal eye wash is a basic first aid supply for any work environment, but ... do you rinse first if a dangerous substance enters both eyes? It’s one less decision, ... its unique dual eye piece. , “Whether its dirt and debris, or an acid or ...
(Date:10/11/2017)... ... , ... Disappearing forests and increased emissions are the main causes of the ... Especially those living in larger cities are affected by air pollution related diseases. , ... pollution-affected countries globally - decided to take action. , “I knew I had to ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the ... won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to ... Experience from US2020. , US2020’s mission is to change the trajectory of STEM ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee is ... honoring scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. ... world’s leading conference and exposition for laboratory science, which will be held February ...
Breaking Biology Technology:
(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
(Date:4/17/2017)... MELBOURNE, Florida , April 17, 2017 ... security technology company, announces the filing of its 2016 Annual Report ... Securities and Exchange Commission. ... Report on Form 10-K is available in the Investor Relations section ... well as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
Breaking Biology News(10 mins):